CLINICAL_TRIALS
research
· 2025-09-15
Clinical Trial Update: HighLife Clarity Treatment of Severe Mitral Regurgitation [NA]
Summary
A clinical trial update from HighLife SAS describes the HighLife Clarity treatment for severe mitral valve regurgitation, with the study not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: HighLife SAS | Conditions: Mitral Valve (MV) Regurgitation | NA | Status: NOT_YET_RECRUITING